In the BioHarmony Drug Report Database
Azatadine
Optimine (azatadine) is a small molecule pharmaceutical. Azatadine was first approved as Optimine on 1982-01-01. It is used to treat allergic rhinitis perennial, allergic rhinitis seasonal, ear diseases, respiration disorders, and urticaria in the USA.
Trade Name
|
Optimine |
|---|---|
Common Name
|
azatadine |
ChEMBL ID
|
CHEMBL946 |
Indication
|
allergic rhinitis perennial, allergic rhinitis seasonal, ear diseases, respiration disorders, urticaria |
Drug Class
|
Tricyclic histaminic-H1 receptor antagonists, loratadine derivatives |
Image (chem structure or protein)